Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock Singapore S.E.
Equities
T14
CNE100000924
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2 USD | +1.52% | +0.50% | -3.38% |
Sales 2024 * | 9.05B 1.25B 1.71B | Sales 2025 * | 9.96B 1.37B 1.88B | Capitalization | 22.49B 3.1B 4.24B |
---|---|---|---|---|---|
Net income 2024 * | 1.17B 162M 221M | Net income 2025 * | 1.4B 193M 264M | EV / Sales 2024 * | 2.48 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 2.26 x |
P/E ratio 2024 * |
22.6
x | P/E ratio 2025 * |
18.9
x | Employees | 4,619 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 31.08% |
1 day | +1.52% | ||
1 week | +0.50% | ||
Current month | -0.50% | ||
1 month | +2.56% | ||
3 months | +10.50% | ||
6 months | +8.11% | ||
Current year | -3.38% |
Managers | Title | Age | Since |
---|---|---|---|
Lei Wang
CEO | Chief Executive Officer | 53 | 22-08-21 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
42 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ping Zhang
BRD | Director/Board Member | 55 | 19-09-29 |
Yoke Pheng Liew
BRD | Director/Board Member | 68 | 20-06-04 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2 | +1.52% | 400,900 |
24-04-25 | 1.97 | -1.01% | 322,000 |
24-04-24 | 1.99 | 0.00% | 198,600 |
24-04-23 | 1.99 | +0.51% | 161,800 |
24-04-22 | 1.98 | -0.50% | 104,400 |
Delayed Quote Singapore S.E., April 26, 2024 at 04:59 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.13% | 4.51B | |
-9.75% | 3.15B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
+0.09% | 1.65B | |
-7.89% | 1.68B | |
-12.97% | 1.53B | |
+33.40% | 1.38B | |
+34.29% | 1.3B |
- Stock Market
- Equities
- 600329 Stock
- T14 Stock